Your Comments On...

Venture-Backed IPO Tally: Zero

Eight months ago, medical treatment firm Broncus Technologies was ready to sell its stock to the public. The company, which develops treatments for lung diseases, filed the paperwork, talked with major banks and waited for the perfect time to make its debut on the public stock market.
 - 

By Kim Hart

 
Comments
© 2008 The Washington Post Company